IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,093,232 | +102.4% | 28,477 | 0.0% | 0.01% | +125.0% |
| Q2 2023 | $540,209 | +55.6% | 28,477 | +27.2% | 0.00% | +33.3% |
| Q1 2023 | $347,269 | -9.6% | 22,390 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $384,234 | +218.1% | 21,647 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $120,790 | -13.0% | 21,647 | -14.0% | 0.00% | 0.0% |
| Q1 2022 | $138,764 | +238.8% | 25,184 | +423.9% | 0.00% | – |
| Q4 2021 | $40,956 | -68.6% | 4,807 | -68.0% | 0.00% | -100.0% |
| Q3 2021 | $130,428 | +193.2% | 15,009 | +256.6% | 0.00% | – |
| Q2 2021 | $44,489 | -81.5% | 4,209 | -72.0% | 0.00% | -100.0% |
| Q1 2021 | $240,712 | -65.3% | 15,007 | 0.0% | 0.00% | -71.4% |
| Q4 2020 | $693,173 | +31.3% | 15,007 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $528,096 | +129.6% | 15,007 | +58.9% | 0.01% | +100.0% |
| Q2 2020 | $230,034 | – | 9,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |